The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.
22 April 2024
Chrysalis Investments Limited ("Chrysalis" or the "Company")
Update on claim against Revolution Beauty Group PLC ("Revolution Beauty")
Further to comments made in the Company's FY23 Financial Report and Audited Financial Statements, the Company has not been satisfied with the limited responses received from Revolution Beauty and its legal advisers to date, and accordingly the Company issued draft Particulars of Claim to Revolution Beauty on 19 April 2024. The draft Particulars of Claim note a claim of £39m, together with a claim for consequential losses of a further £6.2m. The Company considers that it has a strong case and is willing to pursue it.
END
|
For further information, please contact
Media Montfort Communications Charlotte McMullen / Imogen Saunders |
+44 (0) 7921 881 800 chrysalis@montfort.london |
|
|
|
|
Chrysalis Investment Partners LLP: James Simpson
|
+44 (0) 20 7871 5343 |
|
Liberum: Chris Clarke / Darren Vickers / Owen Matthews
|
+44 (0) 20 3100 2000 |
|
Deutsche Numis: Nathan Brown / Matt Goss
|
+44 (0) 20 7260 1000 |
|
Apex Administration (Guernsey) Limited: Chris Bougourd |
+44 (0) 20 3530 3109 |
LEI: 213800F9SQ753JQHSW24
A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk
The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.
This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
